[AKRO] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
13-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 23.86%
YoY- -121.67%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -29,711 -21,403 -16,207 -11,886 -15,611 -15,554 -7,228 155.50%
Tax -11 -6 -1,323 -1,237 -46 -16,309 -7,609 -98.69%
NP -29,711 -21,403 -16,207 -11,886 -15,611 -15,554 -7,228 155.50%
Tax Rate - - - - - - - -
Total Cost 29,711 21,403 16,207 11,886 15,611 15,554 7,228 155.50%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.86 -0.63 -0.57 -0.42 -0.55 -0.56 -2.21 -46.54%
EPS Diluted -0.86 -0.63 -0.57 -0.42 -0.55 -0.56 -2.21 -46.54%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.